<DOC>
	<DOCNO>NCT01406769</DOCNO>
	<brief_summary>This phase II trial study bioimpedance spectroscopy detect lower-extremity lymphedema patient stage I , stage II , stage III , stage IV vulvar cancer undergo surgery lymphadenectomy . Diagnostic procedure , bioimpedance spectroscopy , may help doctor predict onset lower-extremity lymphedema patient vulvar cancer undergo surgery .</brief_summary>
	<brief_title>Bioimpedance Spectroscopy Detecting Lower-Extremity Lymphedema Patients With Stage I , Stage II , Stage III , Stage IV Vulvar Cancer Undergoing Surgery Lymphadenectomy</brief_title>
	<detailed_description>OBJECTIVES : I . To evaluate sensitivity , specificity , feasibility bioimpedance technology compare clinically derive measurement include circumferential volumetric measurement detect lower-extremity lymphedema patient undergoing inguinal lymphadenectomy concurrent surgical management vulvar cancer . OUTLINE : This multicenter study . Patients undergo preoperative postoperative lower-extremity lymphedema assessment comprise serial circumferential measurement , bioimpedance spectroscopy measurement , clinical evaluation use Stemmer sign . Patients undergo radical vulvectomy radical local excision prescribe GOG-0244 , unilateral bilateral inguinal inguinal-femoral lymphadenectomy . After completion study , patient follow 4-6 week , every 3 month 1 year , every 6 month 1 year .</detailed_description>
	<mesh_term>Postoperative Complications</mesh_term>
	<mesh_term>Lymphedema</mesh_term>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<criteria>Patients vulvar cancer already enrol onto Gynecologic Oncology Group ( GOG ) 0244 undergo undergone definitive surgery primary stage IIV vulvar cancer receive radical vulvectomy radical local excision concurrent unilateral bilateral inguinal inguinalfemoral lymphadenectomy ; Patients go receive multimodality therapy ( radiation +/ chemotherapy ) undergoing surgery eligible Patients meet preentry requirement Patients must sign approve informed consent authorization permit release personal health information GOG0269 GOG0244 Patients may undergo sentinel node map long follow full lymphadenectomy operative event Serum Albumin level &gt; = 3.0 within 14 day entry Patients GOG performance status 0 , 1 , 2 Patients enrol onto GOG0244 Patients prior clinical history lower extremity lymphedema Patients history congestive heart failure , chronic renal disease , chronic liver disease Patients prior history chronic low extremity swell Patients GOG Performance Grade 3 4 Patients history invasive malignancy malignancy include bilateral lymph node procedure ( example : bilateral mastectomy axillary lymphadenectomies ) previous cancer treatment include surgical procedure Patients prior low extremity vascular surgery ( arterial venous ) Patients prior pelvic bilateral axillary pelvic , abdominal , inguinal , low extremity radiation therapy Patients go receive another elective surgery operative event inguinal lymphadenectomy vulvar surgery Patients undergo sentinel node biopsy without intention undergo complete lymphadenectomy operative event Patients implanted cardiac device pacemaker implantable cardioverter defibrillator Patients pregnant currently breastfeed Patients treat , risk , bilateral arm lymphedema Patients allergic reaction electrocardiogram ( EKG ) electrodes Patients bilateral auxiliary dissection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>